TURNING POINT THERAPEUTICS I's ticker is TPTX and the CUSIP is 90041T108. A total of 213 filers reported holding TURNING POINT THERAPEUTICS I in Q2 2022. The put-call ratio across all filers is 3.08 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2022 | $749,000 | +72.2% | 9,959 | +9.2% | 0.00% | – |
Q4 2021 | $435,000 | -37.7% | 9,121 | -13.2% | 0.00% | – |
Q3 2021 | $698,000 | -0.3% | 10,513 | +17.2% | 0.00% | – |
Q2 2021 | $700,000 | -20.0% | 8,968 | -3.1% | 0.00% | – |
Q1 2021 | $875,000 | -68.6% | 9,255 | -59.5% | 0.00% | -100.0% |
Q4 2020 | $2,788,000 | +157.7% | 22,880 | +84.7% | 0.00% | 0.0% |
Q3 2020 | $1,082,000 | +225.9% | 12,389 | +141.6% | 0.00% | – |
Q2 2020 | $332,000 | -20.2% | 5,127 | -23.2% | 0.00% | -100.0% |
Q4 2019 | $416,000 | – | 6,674 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Cormorant Asset Management, LP | 3,037,042 | $236,950,000 | 8.05% |
MPM BioImpact LLC | 269,186 | $21,002,000 | 3.45% |
Logos Global Management LP | 400,000 | $31,208,000 | 2.62% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 121,541 | $9,481,000 | 2.50% |
Orbimed Advisors | 2,361,327 | $184,231,000 | 1.86% |
First Light Asset Management, LLC | 395,825 | $30,882,000 | 1.85% |
SECTORAL ASSET MANAGEMENT INC | 211,650 | $16,513,000 | 1.34% |
Nicholas Investment Partners, LP | 224,876 | $17,545,000 | 1.10% |
DAFNA Capital Management LLC | 47,852 | $3,733,000 | 0.78% |
Eventide Asset Management | 578,000 | $45,096,000 | 0.61% |